U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073469) titled 'Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial' on July 09.
Brief Summary: The primary hypothesis being tested in this trial is that ischemic stroke patients in posterior circulation at 4.5 - 24 hours post onset of stroke will have improved clinical outcomes when given intravenous TNK compared to standard care.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Stroke Ischemic
Intervention:
DRUG: Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: S...